Drugs & Targets
- Cancer research beset by a Gordian Knot of problems
- Peter Boyle, one of the great epidemiologists of our time, dies at 71
- As U.S. News tweaks methodology, top four cancer hospitals remain unchanged from last year
(1) MD Anderson, (2) MSK, (3) Mayo, (4) DFCI
- Flatiron CEO Carolyn Starrett: We’re reimagining the infrastructure of cancer care, and we’re going global
- What are you reading in 2022?
- Patient navigation improves outcomes and addresses health equity across the cancer continuum